HORIZON-EIC-2022-PATHFINDERCHALLENGES-01-03
HORIZON-EIC-2022-PATHFINDERCHALLENGES-01-03
Programme: Horizon Europe
7 projects · €30,487,920 total EU contribution (project-level) · 39 participating organizations · 13 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€30,487,920
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (7)
- Netherlands (7)
- France (6)
- Italy (5)
- Spain (3)
- FI (2)
- PT (2)
- SE (2)
- BE (1)
- CZ (1)
- MT (1)
- NO (1)
- UK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- FNUSA ICRC2 projects · CZ
- MDC2 projects · DE
- STICHTING AMSTERDAM UMC2 projects · NL
- UMC UTRECHT2 projects · NL
- UNIVERSITEIT MAASTRICHT2 projects · NL
- Leiden University Medical Center1 projects · NL
- AccelBio1 projects · PT
- CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES1 projects · FR
- CNIC1 projects · ES
- ITB1 projects · IT
- DHM1 projects · DE
- ERASMUS MC1 projects · NL
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families. DCM-NEXT · 101115416 | HORIZON | €4,137,669 | €0 | Details |
MultiomIcs based Risk stratification of Atherosclerotic CardiovascuLar disEase MIRACLE · 101115381 | HORIZON | €4,599,866 | €374,063 | Details |
NaV1.5 regulation fine-tuning as a therapy for cardiac Conduction and Arrhythmic diseases at Risk of suddEn Death NaV1.5-CARED · 101115295 | HORIZON | €4,892,256 | €178,164 | Details |
Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair Interventions CARDIOREPAIR · 101115574 | HORIZON | €4,617,351 | €2,171,805 | Details |
B-specific: B-cell related gene and protein markers with prognostic and therapeutic value for CVD B-specific · 101115159 | HORIZON | €4,006,600 | €250,000 | Details |
Cardiogenomics meets Artificial Intelligence: a step forward in arrhythmogenic cardiomyopathy diagnosis and treatment IMPACT · 101115536 | HORIZON | €4,234,337 | €449,719 | Details |
A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial Infarction TargetMI · 101114924 | HORIZON | €3,999,840 | €3,179,815 | Details |